Northern Trust
TNYA icon

Northern Trust’s Tenaya Therapeutics TNYA Stock Holding History

Northern Trust’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
346,371
+35,717
+11% +$27.1K ﹤0.01% 3860
2026
Q1 		$215K Buy
310,654
+69,074
+29% +$51K ﹤0.01% 3925
2025
Q4 		$172K Buy
241,580
+2,091
+0.9% +$2.84K ﹤0.01% 4028
2025
Q3 		$388K Buy
239,489
+110,044
+85% +$111K ﹤0.01% 3738
2025
Q2 		$79.1K Sell
129,445
-315,595
-71% -$161K ﹤0.01% 4156
2025
Q1 		$254K Sell
445,040
-27,439
-6% -$27.1K ﹤0.01% 3854
2024
Q4 		$676K Buy
472,479
+27,632
+6% +$61.9K ﹤0.01% 3545
2024
Q3 		$859K Buy
444,847
+50,843
+13% +$144K ﹤0.01% 3412
2024
Q2 		$1.22M Sell
394,004
-3,657
-0.9% -$15.1K ﹤0.01% 3154
2024
Q1 		$2.08M Buy
397,661
+7,979
+2% +$38.2K ﹤0.01% 2936
2023
Q4 		$1.26M Sell
389,682
-39,551
-9% -$85.4K ﹤0.01% 3231
2023
Q3 		$1.09M Buy
429,233
+11,625
+3% +$48.7K ﹤0.01% 3263
2023
Q2 		$2.45M Buy
417,608
+69,664
+20% +$405K ﹤0.01% 2894
2023
Q1 		$992K Buy
347,944
+124,832
+56% +$351K ﹤0.01% 3224
2022
Q4 		$448K Sell
223,112
-7,707
-3% -$18.8K ﹤0.01% 3546
2022
Q3 		$670K Buy
230,819
+8,704
+4% +$40.6K ﹤0.01% 3413
2022
Q2 		$1.25M Sell
222,115
-9,344
-4% -$75.6K ﹤0.01% 3282
2022
Q1 		$2.73M Buy
231,459
+91,586
+65% +$1.11M ﹤0.01% 2938
2021
Q4 		$2.65M Buy
139,873
+16,583
+13% +$361K ﹤0.01% 3078
2021
Q3 		$2.54M Buy
+123,290
New +$2.65M ﹤0.01% 3147

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust's TNYA Position: Q2 2026 in Review

Northern Trust increased its Tenaya Therapeutics (TNYA) stake by 11% in Q2 2026, buying an estimated $27.1K and bringing the position to 346,371 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #3860.

Northern Trust first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.73M in Q1 2022. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Northern Trust held 346,371 shares of Tenaya Therapeutics worth $256K as of Q2 2026.
  • Northern Trust bought 35,717 Tenaya Therapeutics shares in Q2 2026, an estimated $27.1K.
  • Tenaya Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3860 holding.
  • Northern Trust first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Northern Trust's Tenaya Therapeutics position peaked at $2.73M in Q1 2022.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.